Search Results - "Leyva Fernández, Laura"

Neuromyelitis optica is an HLA associated disease different from Multiple Sclerosis: a systematic review with meta-analysis by Alvarenga, Marcos Papais, do Carmo, Luciana Ferreira, Vasconcelos, Claudia Cristina Ferreira, Alvarenga, Marina Papais, Alvarenga-Filho, Helcio, de Melo Bento, Cleonice Alves, Paiva, Carmen Lucia Antão, Leyva-Fernández, Laura, Fernández, Óscar, Papais-Alvarenga, Regina Maria

“…Neuromyelitis Optica and Multiple Sclerosis are idiopathic inflammatory demyelinating diseases of the central nervous system that currently are considered…”
Get full text

Natalizumab-immunogenicity evaluation in patients with infusion related events or disease exacerbations by Ciano-Petersen, Nicolás Lundahl, Aliaga-Gaspar, Pablo, Hurtado-Guerrero, Isaac, Reyes, Virginia, Rodriguez-Bada, José Luis, Rodriguez-Traver, Eva, Brichette-Mieg, Isabel, Leyva Fernández, Laura, Serrano-Castro, Pedro, Alonso, Ana, Oliver-Martos, Begoña

“…IntroductionNatalizumab is a biologic drug for relapsing-remitting multiple sclerosis that may induce the generation of anti-drug antibodies in some patients…”
Get full text

Evaluation of the effectiveness of a new cryopreservation system based on a two-compartment vial for the cryopreservation of cell therapy products by Rosell-Valle, Cristina, Antúnez, Cristina, Campos, Fernando, Gallot, Natalia, García-Arranz, Mariano, García-Olmo, Damian, Gutierrez, Rosario, Hernán, Roberto, Herrera, Concha, Jiménez, Rosario, Leyva-Fernández, Laura, Maldonado-Sanchez, Rafael, Muñoz-Fernández, Raquel, Nogueras, Sonia, Ortiz, Lourdes, Piudo, Inmaculada, Ranchal, Isidora, Rodríguez-Acosta, Antonio, Segovia, Cristina, Fernández-Muñoz, Beatriz

“…Successful cell cryopreservation and banking remain a major challenge for the manufacture of cell therapy products, particularly in relation to providing a…”
Get full text

Killer cell immunoglobulin-like receptor genes in Spanish multiple sclerosis patients by García-León, Juan A., Pinto-Medel, María J., García-Trujillo, Lucía, López-Gómez, Carlos, Oliver-Martos, Begoña, Prat-Arrojo, Isidro, Marín-Bañasco, Carmen, Suardíaz-García, Margarita, Maldonado-Sanchez, Rafael, Fernández-Fernández, Óscar, Leyva-Fernández, Laura

“…► The frequency of the KIR2DL5 and KIR3DS1 genes were increased in MS patients. ► The carriage of the KIR2DL1 gene was associated with a higher progression…”
Get full text

Mesenchymal properties of SJL mice-stem cells and their efficacy as autologous therapy in a relapsing-remitting multiple sclerosis model by Marin-Bañasco, Carmen, Suardíaz García, Margarita, Hurtado Guerrero, Issac, Maldonado Sánchez, Rafael, Estivill-Torrús, Guillermo, Leyva Fernández, Laura, Fernández Fernández, Oscar

“…Mesenchymal stem cells (MSCs) are a multipotent population of adult stem cells, which may represent a promising therapeutic approach for neurological…”
Get full text

Mes de nacimiento, HLA-DRB1 y riesgo de esclerosis múltiple en la descendencia by Guijarro-Castro, Cristina, Sánchez Zapardiel, Elena, Muñoz García, Delicias, Fernández Fernández, Óscar, Leyva Fernández, Laura, Castro Panete, María José, Picón Muñoz, Carmen, Talise, Marta, Martínez Feito, Ana, Paz Artal, Estela

Get full text

Characterization of Ad-MSC genetically modified to produce IFNbeta. Effectiveness in RR-EAE model by García, Margarita Suardíaz, Marín-bañasco, Carmen, Benabdellah, Karim, Fernandez, Laura Leyva, Martos, Begoña Oliver, Medel, Maria Jesus Pinto, Molina, Francisco Martín, Fernández, Oscar Fernández

Get full text

Respuesta al interferón beta en la esclerosis múltiple asociada con la discapacidad previa al tratamiento by Fernández Fernández, Óscar, Fernández Sánchez, Victoria Eugenia, Mayorga, C., Guerrero Fernández, Miguel, León, A., Tamayo Toledo, José A., Alonso, A., Romero, F., Leyva Fernández, Laura, Luque, G., de Ramón Garrido, Enrique

Get full text